SG Americas Securities
GSK icon

SG Americas Securities’s GSK GSK Stock Holding History

SG Americas Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-158,400
Closed -$30K – 3394
2016
Q2 		$30K Buy
+158,400
New +$8.34M ﹤0.01% 2490

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SG Americas Securities's GSK Position: Q2 2026 in Review

SG Americas Securities reduced its GSK (GSK) stake by 63% in Q2 2026, selling an estimated $381K and leaving 4,154 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

SG Americas Securities first reported a position in GSK in Q1 2014 and has held it in 42 quarters since. The position peaked at $19.7M in Q2 2021. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • SG Americas Securities held 4,154 shares of GSK worth $218K as of Q2 2026.
  • SG Americas Securities sold 7,209 GSK shares in Q2 2026, an estimated $381K.
  • GSK made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2762 holding.
  • SG Americas Securities first reported a position in GSK in Q1 2014 and has held it in 42 quarters since.
  • SG Americas Securities's GSK position peaked at $19.7M in Q2 2021.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.